Emboline key facts
as of Oct 2026- Developer of an embolic protection catheter designed to offer embolic protection during percutaneous heart valve repair and replacement procedures.
- Emboline is valued at approximately $151.4M as of Oct 2026, set at its later-stage round, Jun 2021; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $102.0M across 2 recorded rounds; the latest was Later Stage VC ($55.4M) in May 2021.
- Notable investors include Western Technology Investment, ShangBay Capital, SV Tech Ventures, Matrix Capital Management, GAM Investments — 12 tracked in total.
- Emboline has filed 3 Form Ds with the SEC since 2020, most recently Jun 2021 ($55.4M sold to 14 investors).
- Status: Privately Held (backing).
Valued at $151.4M at its later-stage round, Jun 2021. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Watch Emboline: the Monday email on marks, rounds and moves
Emboline funding rounds
2 roundsWho backs Emboline
12+Emboline valuation
Emboline was valued at $151 million at its later-stage round in Jun 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Emboline raised?
Emboline has raised $102 million in total; 2 of its rounds are on record. The largest on record was a $55.4 million later-stage round in May 2021.
Emboline has filed 3 Form Ds with the SEC since 2020, most recently in Jun 2021 ($55.4 million sold to 14 investors).
Emboline investors
12 investors are on record for Emboline, including Western Technology Investment, ShangBay Capital, SV Tech Ventures and Matrix Capital Management. The later-stage round in May 2021 drew 14 investors.
About Emboline
Developer of an embolic protection catheter designed to offer embolic protection during percutaneous heart valve repair and replacement procedures. The company's catheter protects the arterial bed and circumferentially conforms to a wide range of patient anatomies, while the expandable access port accommodates a wide range of procedural devices, enabling medical providers to provide complete protection of the brain and other critical organs by capturing and removing emboli produced during the procedure.
- Sector
- Healthcare
- HQ
- Santa Cruz, CA, United States
- Founded
- 2011
- Employees
- 23
- Website
- emboline.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.